4-Me-1-(2-(1H-tetrazol-5-yl)ethyl)benzene sulfonate and N-2-(1H-tetrazol-5-yl)ethyl methanesulfonamide
US4423224A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Sep 8, 1980 |
| Grant date | Dec 27, 1983 |
| Priority date | — |
| Expiry date | Sep 8, 2000 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
At least one compound defined by one of the following formulae: ##STR1## where X represents Cl, Br, ##STR2## or--SCH.sub.3, and n is 1 or 2; and EQU CH.sub.3 SO.sub.2 NHCH.sub.2 CH.sub.2 CN (II) have been administered to animals to improve the efficiency of food utilization by these animals. These compounds can be administered orally by combining the compounds with feed compositions and fed to animals such as ruminants with a developed rumen function as well as other animals that ferment fibrous material and vegetable matter in the cecum or colon. These compounds effect the rumen metabolism to increase the production of propionate relative to other volatile fatty acids, particularly acetate and to inhibit methanogenesis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.